Annual Drug Patent Expirations for AXUMIN Axumin is a drug marketed by Blue Earth and is included in one NDA. It is available from one supplier. There are seven patents…
Source
This chart shows the drugs with the most patents in Chile. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source
Which pharmaceutical drugs have the most drug patents in Chile? Read Post »
Annual Drug Patent Expirations for ALVAIZ Alvaiz is a drug marketed by Teva Pharms Inc and is included in one NDA. It is available from one supplier. The generic ingredient…
Source
Annual Drug Patent Expirations for SELENIOUS+ACID Selenious Acid is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. The generic ingredient…
Source
Annual Drug Patent Expirations for TRALEMENT Tralement is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are two patents…
Source
Annual Drug Patent Expirations for MULTRYS Multrys is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are two patents…
Source
In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden. The focus of the discussion is on patent litigation strategies…
Source
Crucial Insights on Patent Litigation Strategies in Pharma Industry Read Post »
This chart shows the patent expirations for solution dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
Source
Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Bristol-myers and is included in one NDA. It is available from three suppliers. There are eleven patents protecting…
Source
New patent expiration for Bristol-myers drug ABRAXANE Read Post »
This chart shows the patent expirations for solution dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
Source
Get new actionable insights and updates from BiotechBlog
